7490
Y. Kong et al. / Tetrahedron 69 (2013) 7487e7491
128.1, 128.5, 129.4, 130.0, 131.1, 134.0, 134.7, 143.9, 145.4; HRMS
(ESI): MHþ, found: 315.1158. C17H19N2O2S requires 315.1162.
129.6, 134.0, 135.2, 139.7, 144.2, 144.5, 149.2; HRMS (ESI): MHþ,
found 355.1107. C19H19N2O3S requires 355.1111.
4.3.9. Preparation of N-methyl-N0-(furan-20-ylmethylene)-4-methyl
benzenesulfonohydrazide (2j). Compound 2j (50 mg, 99%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol), 1d (48 mg, 0.18 mmol), PPh3 (15 mg,
0.06 mmol), and iodomethane (28 mg, 0.20 mmol) as yellow oil. dH
(400 MHz, CDCl3) 2.40 (3H, s), 3.15 (3H, s), 6.46 (1H, d, J 1.2 Hz), 6.71
(1H, d, J 3.2 Hz), 7.29 (2H, d, J 8.4 Hz), 7.49 (1H, s), 7.55 (1H, s), 7.77
(2H, d, J 8.4 Hz); dC (100 MHz, CDCl3) 21.5, 33.9, 111.7, 112.4, 128.2,
129.4, 133.0, 135.4, 144.1, 144.3, 149.6; HRMS (ESI): MHþ, found:
279.0802. C13H15N2O3S requires 279.0798.
4.3.3. Preparation of N-benzyl-N0-(10-phenylethylidene)-4-methy
lbenzenesulfonohydrazide (2d). Compound 2d (64 mg, 92%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol),1b (53 mg, 0.18 mmol), PPh3 (14 mg, 0.05 mmol),
and benzyl bromide (35 mg, 0.20 mmol) as white crystalline solid.
Mp 116e120 ꢀC; dH (400 MHz, CDCl3) 2.17 (3H, s), 2.48 (3H, s), 4.25
(2H, s), 7.23e7.25 (5H, m), 7.34e7.43 (5H, m), 7.66 (2H, d, J 7.2 Hz),
7.78 (2H, d, J 8.0 Hz); dC (100 MHz, CDCl3) 17.8, 21.6, 56.6, 127.1, 127.7,
128.2, 129.1, 129.4,129.7, 130.8,132.0,135.4,137.1, 144.1, 178.3; HRMS
(ESI): MHþ, found: 379.1479. C22H23N2O2S requires 379.1475.
4.3.10. Preparation of N-allyl-N0-(furan-20-ylmethylene)-4-methyl
benzenesulfonohydrazide (2k). Compound 2k (55 mg, 99%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol), 1d (48 mg, 0.18 mmol), PPh3 (15 mg,
0.06 mmol), and allyl bromide (34 mg, 0.20 mmol) as yellow crys-
talline solid. Mp 96e98 ꢀC; dH (400 MHz, CDCl3) 2.41 (3H, s), 4.23
(2H, d, J 4.4 Hz), 5.19e5.27 (2H, m), 5.73e5.79 (1H, m), 6.46 (1H, dd, J
3.2, 1.6 Hz), 6.71 (1H, d, J 3.2 Hz), 7.31 (2H, d, J 8.0 Hz), 7.49 (1H, s),
7.78(1H, s), 7.79 (2H, d, J 8 Hz); dC (100 MHz, CDCl3) 21.5, 50.8, 111.8,
113.2,118.3,128.2,129.5,131.2,134.2,138.8,144.1,144.5,149.4; HRMS
(ESI): MHþ, found: 305.0959. C15H17N2O3S requires 305.0954.
4.3.4. Preparation of N-methyl-N0-(10-phenylethylidene)-4-methy
lbenzenesulfonohydrazide (2e). Compound 2e (53 mg, 95%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol),1b (53 mg, 0.18 mmol), PPh3 (14 mg, 0.05 mmol),
and iodomethane (29 mg, 0.20 mmol) as white crystalline solid. Mp
128e130 ꢀC; dH (400 MHz, CDCl3) 2.45 (3H, s), 2.57 (3H, s), 2.81 (3H,
s), 7.36e7.46 (5H, m), 7.77e7.80 (4H, m); dC (100 MHz, CDCl3) 16.8,
21.5, 39.2, 127.0, 128.3, 129.2, 129.4, 130.8, 137.0, 144.0, 174.2; HRMS
(ESI): MHþ, found 303.1166. C16H19N2O2S requires 303.1162.
4.3.5. Preparation of N-allyl-N0-(10-phenylethylidene)-4-methy
lbenzenesulfonohydrazide (2f). Compound 2f (60 mg, 99%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol), 1b (53 mg, 0.18 mmol), PPh3 (14 mg,
0.05 mmol), and allyl bromide (24 mg, 0.20 mmol) as colorless oil.
dH (400 MHz, CDCl3) 2.45 (3H, s), 2.59 (3H, s), 3.76 (2H, d, J 6.4 Hz),
5.04e5.11 (2H, m), 5.68e5.72 (1H, m), 7.34e7.48 (5H, m), 7.72 (2H,
d, J 8.0 Hz), 7.79 (2H, d, J 7.2 Hz); dC (100 MHz, CDCl3) 18.1, 21.6, 55.4,
119.5, 127.1, 128.4, 129.0, 129.2, 129.4, 130.9, 132.1, 137.2, 144.1, 177.7;
HRMS (ESI): MHþ, found: 329.1322. C18H21N2O2S requires 329.1318.
4.3.11. Preparation of N-benzyl-N0-(30-phenylpropylidene)-4-methyl
benzenesulfonohydrazide (2l). Compound 2l (83 mg, 84%) was
prepared following the procedure described for 2a by using K2CO3
(52 mg, 0.38 mmol), 1e (76 mg, 0.25 mmol), PPh3 (20 mg,
0.08 mmol), and benzyl bromide (47 mg, 0.27 mmol) as yellow
crystalline solid. Mp 88e90 ꢀC; dH (400 MHz, CDCl3) 2.44 (3H, s),
2.45e2.51 (2H, m), 2.68 (2H, t, J 7.6 Hz), 4.54 (2H, s), 6.98 (2H, d, J
7.6 Hz), 7.12e7.32 (11H, m), 7.74 (2H, d, J 8.0 Hz); dC (100 MHz,
CDCl3) 21.6, 32.2, 34.3, 52.6, 126.0, 127.2, 127.5, 128.2, 128.7, 129.5,
134.0, 135.4, 140.4, 143.9, 155.1; HRMS (ESI): MHþ, found: 393.1626.
4.3.6. Preparation of N-benzyl-N0-(propan-20-ylidene)-4-methyl
benzenesulfonohydrazide (2g). Compound 2g (77 mg, 97%) was
prepared following the procedure described for 2a by using K2CO3
(52 mg, 0.38 mmol), 1c (57 mg, 0.25 mmol), PPh3 (20 mg,
0.08 mmol), and benzyl bromide (47 mg, 0.27 mmol) as white
crystalline solid. Mp 127e129 ꢀC; dH (400 MHz, CDCl3) 1.78 (3H, s),
1.92 (3H, s), 2.46 (3H, s), 4.12 (2H, s), 7.24e7.26 (5H, m), 7.37 (2H, d, J
7.6 Hz), 7.74 (2H, d, 8.4 Hz); dC (100 MHz, CDCl3) 20.7, 21.6, 24.8,
56.1, 127.6, 128.2, 128.9, 129.39, 129.44, 129.6, 132.1, 135.5, 144.0;
HRMS (ESI): MHþ, found: 317.1322. C17H21N2O2S requires 317.1318.
C
23H25N2O2S requires 393.1631.
4.3.12. Preparation of N-methyl-N0-(30-phenylpropylidene)-4-methyl
benzenesulfonohydrazide (2m). Compound 2m (63 mg, 79%) was
prepared following the procedure described for 2a by using K2CO3
(52 mg, 0.38 mmol), 1e (76 mg, 0.25 mmol), PPh3 (20 mg,
0.08 mmol), and iodomethane (39 mg, 0.27 mmol) as colorless oil.
dH (400 MHz, CDCl3) 2.42 (3H, s), 2.59e2.64 (2H, m), 2.81 (2H, t, J
7.6 Hz), 2.98 (3H, s), 7.05 (1H, t, J 4.4 Hz), 7.12 (2H, d, J 6.8 Hz), 7.19
(1H, d, J 6.8 Hz), 7.23e7.28 (4H, m), 7.68 (2H, d, J 8.0 Hz); dC
(100 MHz, CDCl3) 21.5, 32.5, 33.7, 34.2, 126.0, 128.3, 128.4, 129.3,
132.8, 140.5, 143.8, 149.1; HRMS (ESI): MHþ, found: 317.1322.
4.3.7. Preparation of N-allyl-N0-(propan-20-ylidene) -4-methyl
benzenesulfonohydrazide (2h). Compound 2h (44 mg, 89%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol), 1c (42 mg, 0.19 mmol), PPh3 (15 mg,
0.06 mmol), and allyl bromide (25 mg, 0.21 mmol) as colorless oil.
dH (400 MHz, CDCl3) 2.08 (3H, s), 2.19 (3H, s), 2.43 (3H, s), 3.62 (2H,
d, J 6.0 Hz), 5.06e5.11 (2H, m), 5.63e5.70 (1H, m), 7.33 (2H, d, J
8.0 Hz), 7.68 (2H, d, J 8.0 Hz); dC (100 MHz, CDCl3) 21.1, 21.5, 25.0,
54.9, 119.4, 128.9, 129.3, 131.8, 132.2, 144.0, 181.3; HRMS (ESI): MHþ,
found: 267.1165. C13H19N2O2S requires 267.1162.
C17H21N2O2S requires 317.1318.
4.3.13. Preparation of N-allyl-N0-(30-phenylpropylidene)-4-
methylbenzenesulfonohydrazide (2n). Compound 2n (56 mg, 90%)
was prepared following the procedure described for 2a by using
K2CO3 (38 mg, 0.28 mmol), 1e (55 mg, 0.18 mmol), PPh3 (15 mg,
0.06 mmol), and allyl bromide (24 mg, 0.20 mmol) as yellow oil. dH
(400 MHz, CDCl3) 2.42 (3H, s), 2.58e2.63 (2H, m), 2.82 (2H, t, J
7.6 Hz), 4.04 (2H, d, J 4.4 Hz), 5.12 (2H, d, J 12.4 Hz), 5.64 (1H, dt, J
17.2, 5.2 Hz), 7.13 (2H, d, J 7.2 Hz), 7.19 (1H, d, J 6.8 Hz), 7.23e7.28
(5H, m), 7.69 (2H, d, 8.4 Hz); dC (100 MHz, CDCl3) 21.5, 32.3, 34.3,
50.7, 118.1, 126.1, 128.2, 128.4, 129.4, 131.5, 134.1, 140.5, 143.8, 154.0;
HRMS (ESI): MHþ, found: 343.1471. C19H23N2O2S requires 343.1475.
4.3.8. Preparation of N-benzyl-N0-(furan-20-ylmethylene)-4-methyl
benzenesulfonohydrazide (2i). Compound 2i (61 mg, 95%) was
prepared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol), 1d (48 mg, 0.18 mmol), PPh3 (15 mg,
0.09 mmol), and benzyl bromide (34 mg, 0.20 mmol) as white
crystalline solid. Mp 120e122 ꢀC; dH (400 MHz, CDCl3) 2.42 (3H, s),
4.73 (2H, s), 6.40 (1H, s), 6.61 (1H, d, J 3.6 Hz), 7.24e7.27 (1H, m),
7.31e7.34 (6H, m), 7.43 (1H, s), 7.62 (1H, s), 7.83 (2H, d, J 8.0 Hz); dC
(100 MHz, CDCl3) 21.5, 52.7, 111.7, 113.5, 127.1, 127.6, 128.2, 128.8,
4.3.14. Preparation of N-benzyl-N0-cyclohexylidene-4-methylben
zenesulfonohydrazide (2o). Compound 2o (56 mg, 85%) was pre-
pared following the procedure described for 2a by using K2CO3
(38 mg, 0.28 mmol),1f (49 mg, 0.18 mmol), PPh3 (15 mg, 0.06 mmol),
and benzyl bromide (35 mg, 0.20 mmol) as white crystalline solid.